Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
The current Haemonetics(HAE) stock price is $79.90, with a market capitalization of 3.74B. The stock trades at a price-to-earnings (P/E) ratio of 23.33.
On 2025-12-18, Haemonetics(HAE) stock moved within a range of $79.53 to $80.96. With shares now at $79.90, the stock is trading +0.5% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 684.66K, compared to an average daily volume of 935.86K.
The stock's 52-week range extends from a low of $47.32 to a high of $87.32.
The stock's 52-week range extends from a low of $47.32 to a high of $87.32.
HAE News
Haemonetics (HAE) just took a hit after Needham cut the stock to Hold, citing rising competition from Abbott and Cordis in vascular closure devices and raising...
Baird raised the firm’s price target on Haemonetics (HAE) to $99 from $87 and keeps an Outperform rating on the shares. The firm updated its model after its pro...
Needham downgraded Haemonetics (HAE) to Hold from Buy without a price target The firm’s checks indicate rising concern around competition for Haemonetics’ vascu...
Analyst ratings
64%
of 11 ratingsMore HAE News
Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS syst...
